9-35737270-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020944.3(GBA2):āc.2683C>Gā(p.His895Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,588 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_020944.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GBA2 | NM_020944.3 | c.2683C>G | p.His895Asp | missense_variant | 17/17 | ENST00000378103.7 | NP_065995.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GBA2 | ENST00000378103.7 | c.2683C>G | p.His895Asp | missense_variant | 17/17 | 1 | NM_020944.3 | ENSP00000367343 | P1 | |
GBA2 | ENST00000378094.4 | c.*206C>G | 3_prime_UTR_variant | 17/17 | 1 | ENSP00000367334 | ||||
GBA2 | ENST00000378088.1 | c.*367C>G | 3_prime_UTR_variant | 2/2 | 2 | ENSP00000367328 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461588Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 727106
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Spastic paraplegia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 02, 2018 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The aspartic acid amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with GBA2-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change replaces histidine with aspartic acid at codon 895 of the GBA2 protein (p.His895Asp). The histidine residue is weakly conserved and there is a moderate physicochemical difference between histidine and aspartic acid. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at